Cannabis company Tilray surges in Nasdaq debut: Reuters
Private equity-backed Canadian medical marijuana company Tilray Inc rose more than 35 percent in its U.S. trading debut this week after raising about US$153 million ($202 million) in an initial public offering, Reuters reported. Tilray is the third Canadian cannabis company to list on a major U.S. exchange. Its debut values the company at about US$2 billion ($2.6 billion). Seattle-based cannabis private equity firm Privateer Holdings, which has backed Tilray since 2014, will continue to own 82 percent of the business.
19 July 2018•2 mins read
